← All trials
NCT03432312
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 15, 2018
- Primary completion
- Feb 17, 2018
- Completion date
- Feb 17, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 42
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Fertin Pharma A/SLead sponsor
- ParexelOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.